[Effect of 2 N-substituted aminotetralin derivatives with antihypertensive action on the monoamine oxidase activity of brain and liver preparations].
D015081:2-Naphthylamine / Q000031:analogs & derivatives / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009281:Naphthalenes / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012642:Selegiline / Q000494:pharmacology; D013764:Tetrahydronaphthalenes / Q000494:pharmacology*
D000959:Antihypertensive Agents; D008996:Monoamine Oxidase Inhibitors; D009281:Naphthalenes; D013764:Tetrahydronaphthalenes; D012642:Selegiline; C023611:N-(3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-N-(3-oxo-3-phenyl-2-methylpropyl)piperazine; C024116:5,8-dimethoxy-2-(2-hydroxyethyl)amino-3-hydroxy-1,2,3,4-tetrahydronaphthalene; D011433:Propranolol; D015081:2-Naphthylamine; D008995:Monoamine Oxidase
Vliianie na dve N-zamesteni aminotetralinovi proizvodni s antikhipertenzivno deĭstvie vŭrkhu aktivnostta na monoaminooksidazata v preparati ot mozŭk i cheren drob.